Medizinische Universität Innsbruck

Real-world outcomes using PD-1 antibodies and BRAF plus MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland (2022) Schumann K, Mauch C, Klespe KC, Loquai C, Nikfarjam U, Schlaak M, Akcetin L, et al. Journal article Identifying adult hypophosphatasia in the rheumatology unit (2022) Feurstein J, Behanova M, Haschka J, Roetzer K, Uyanik G, Hadzimuratovic B, Witsch-Baumgartner M, et al. Journal article Extent of subclinical atherosclerosis on coronary computed tomography and impact of statins in patients with diabetes without known coronary artery disease: Results from CONFIRM registry (2022) Shaikh K, Ahmed A, Gransar H, Lee JH, Leipsic J, Nakanishi R, Alla V, et al. Journal article On-chip beam rotators, adiabatic mode converters, and waveplates through low-loss waveguides with variable cross-sections (2022) Sun B, Morozko F, Salter PS, Moser S, Pong Z, Patel RB, Walmsley IA, et al. Journal article On the Role of Psychoneuroimmunology in Oral Medicine (2022) Seizer L, Schubert C Journal article, Review article S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid (2022) Hofmann SC, Gunther C, Bockle BC, Didona D, Ehrchen J, Gaskins M, Geerling G, et al. Journal article Evidence-based vertigo therapy;Meta-analysis of randomized primary pharmacotherapy trials Evidenzbasierte Schwindeltherapie: Metaanalyse randomisierter Primärstudien zur Pharmakotherapie (2022) Waldfahrer F, Scholtz AW Journal article MR imaging in children with transverse myelitis and acquired demyelinating syndromes (2022) El Naggar I, Cleaveland R, Wendel EM, Bertolini A, Schanda K, Karenfort M, Thiels C, et al. Journal article Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO) (2022) Rogers S, Baumert BG, Blanck O, Boehmer D, Bostroem J, Engenhart-Cabillic R, Ermis E, et al. Journal article Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial (2022) González-Martín A, Desauw C, Heitz F, Cropet C, Gargiulo P, Berger R, Ochi H, et al. Journal article